Funding Opportunity RFA-OD-24-006 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to seek applications for a Coordinating Center (CC) for the Multi-Sectoral Preventive Interventions (MSPI) Research Network. Members of the Multi-Sectoral Preventive Interventions (MSPI) Research Network, including the CC and separately funded research projects, will work collaboratively with the NIH to test prospective multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities. The MSPI Research Network will include the CC funded under this Cooperative Agreement and up to 10 Research Projects funded under the companion UG3/UH3 Phased Cooperative Agreement NOFO, Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities. The CC will provide overarching support and guidance to the network in three domains: (1) administration, coordination, and communication; (2) methodology, data, and analytic support and consultation; and (3) community and other collaborator engagement and dissemination support. It is important that applicants for the CC also read the companion NOFO to understand the full mission and structure of the research network.

Funding Opportunity RFA-DA-24-036 from the NIH Guide for Grants and Contracts. The goal of the initiative is to test prevention and harm reduction strategies, extending the continuum of care within the U.S. rural communities impacted by the opioid/psychostimulant misuse epidemic to reduce risks for individuals with unmet prevention and harm reduction needs.

Notice NOT-AT-24-024 from the NIH Guide for Grants and Contracts

Notice NOT-AA-24-002 from the NIH Guide for Grants and Contracts

Notice NOT-TR-24-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-288 from the NIH Guide for Grants and Contracts. The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to work with their institutions to apply. This notice of funding opportunity (NOFO) is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should be submitted under this NOFO include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Those not planning an independent clinical trial or basic experimental study with humans, or proposing to gain research experience in a clinical trial or basic experimental study with humans led by another investigator, must apply to the 'Independent Clinical Trial Not Allowed' companion NOFO (PAR-23-286).

Notice NOT-AT-24-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-029 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) seeks applications for a single Coordinating Center to support research on the identification and dissemination of signals of emerging drug use patterns in communities across the United States. The Coordinating Center will provide operational, administrative, and logistical support by executing the following: (1) Establish a Scientific Advisory Group to provide guidance and direction. (2) Engage an Early Warning Network composed of two components: local health experts on drug use from selected communities (Sentinel Sites) and a broader network of community-based health researchers, to support the bi-directional sharing of information and insights into drug use patterns in their communities and to support the ongoing monitoring, interpretation, and dissemination of data. (3) Identify, compile, analyze, and triangulate research data and resources from multiple sources to assess and contextualize emerging drug threats. (4) Disseminate contextualized research findings, data, and resources to key audiences who can use the data to inform their response.

Funding Opportunity RFA-DA-25-027 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network's capacity to respond to urgent public health needs. NIDA intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, community representatives, healthcare providers, and healthcare institutions.

Notice NOT-NR-24-002 from the NIH Guide for Grants and Contracts

Swedish: Senior Bioinformatics Scientist - Swedish First Hill - Seattle, WA Mostly on-site role with some remote flexibility (at program discretion). SCHEDU... Seattle, Washington

Notice NOT-CA-24-001 from the NIH Guide for Grants and Contracts

Notice NOT-TR-24-002 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-054 from the NIH Guide for Grants and Contracts. The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-21-293). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

Funding Opportunity RFA-HG-23-048 from the NIH Guide for Grants and Contracts. This NOFO solicits applications that stimulate innovation and advance understanding of when, where and how best to implement the use and sharing of genomic information and technologies in clinical care in all persons irrespective of racial/ethnic background or socioeconomic status. The R03 grant mechanism supports small research projects that can be carried out in a short period of time with limited resources, such as pilot or feasibility studies; secondary analysis of existing data; small, self-contained research projects; or development of research methodology. An R03 grant application need not have extensive background material or preliminary information. Accordingly, reviewers will emphasize the conceptual framework, the level of innovation, and the potential to significantly advance our knowledge or understanding. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or, when available, from investigator-generated data. Preliminary data are not required for R03 applications; however, they may be included if available.

Notice NOT-AR-23-021 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-034 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-194 from the NIH Guide for Grants and Contracts

GBP35000 - GBP40000 per annum: SRG: PhD Genetic Engineer required, based in Cheshire. Requiring PhD in Molecular Biology, Synthetic Biology, Bioengineering, Biotechnology, Genetics, etc. Chester, England